In the SURMOUNT-1 trial, tirzepatide produced dose-dependent weight reductions, with average losses approaching or exceeding ~20% at higher doses in adults with obesity who did not have diabetes, numbers that markedly exceed historical pharmacotherapy benchmarks
Our medical weight loss program focuses on sustainable results, ensuring that every step of your journey is supported by expert care
A study conducted on 327 non-diabetic individuals who received a once-weekly 2.4 mg dose of semaglutide found that participants regained two-thirds of their lost weight within 1 year of stopping the medication
Both medications require weekly injections that you give yourself at home
Insert the needle quickly and smoothly into the skin to minimize discomfort
"With Ozempic now available as both an injection and oral option under one brand, treatment can be individualized so patients are getting the proven semaglutide medicine that best fits their needs." Ozempic pill is being manufactured end-to-end in the US and will be available through 70,000+ US pharmacies nationwide